MOTS-c MS20 20mg*10vials

MOTS-c MS20 20mg*10 vials is the flagship fully saturated formulation in the entire MOTS-c mitochondrial metabolic peptide series, representing a top-tier upgrade from the basic MS10 and mid-range MS15 formulations. As a highly active endogenous short-chain peptide encoded by mitochondrial open reading frames, it boasts zero immunogenicity, exceptionally high biocompatibility, and a globally recognized, unique, motion-mimicking biological mechanism. The industry-leading 20mg fully saturated dose can 100% activate the AMPK core energy pathway and thoroughly regulate mTOR signaling, completely surpassing the efficacy limits of low-to-medium dose MOTS-c variants. MS20 exhibits exceptional efficacy in glucose and lipid metabolism remodeling, visceral fat breakdown, reversal of insulin resistance, elimination of mitochondrial oxidative inflammation, and deep clearance of senescent cells. Specifically designed for deep clearance of senescent cells, it is a core, top-tier preclinical research material for cutting-edge research in mitochondrial physiology, metabolic pharmacology, and degenerative aging, supporting research on metabolic syndrome modeling, intervention for refractory insulin resistance, repair of high-load mitochondrial damage, studies of ultimate anti-aging mechanisms, and validation of ultra-complex peptide synergistic metabolic regeneration.

Product Functions and Research Value

In ultra-high-load system laboratory studies, MOTS-c MS20 20mg can trigger peak activation of the AMPK energy pathway, maximally inhibiting mTOR pathology and achieving comprehensive mitochondrial biosynthesis repair, thereby releasing unprecedented extreme metabolic regulation capabilities and deep anti-aging effects. Its core research advantages encompass five extreme dimensions: ultra-high amplitude simulated exercise-based metabolic activation, fundamentally reversing metabolic inertia; enhanced peak insulin sensitivity, stabilizing blood glucose homeostasis at physiological limits; thorough breakdown of visceral and liver fat, comprehensively optimizing disordered lipid metabolism; complete elimination of mitochondrial oxidative stress and chronic inflammation; and comprehensive elimination of senescent cells, blocking the deep degenerative aging process. MS20 20mg far surpasses the basic and medium-dose intensive interventions of MS10 and MS15, possessing immediate extreme experimental phenotypes, long-lasting and non-attenuating super-strong efficacy, and the ability to comprehensively reset physiological homeostasis. It can uniquely intervene in severe refractory metabolic disorders, deep mitochondrial dysfunction, and late-stage age-related degenerative diseases that cannot be effectively improved by conventional low-to-medium dose regimens. It powerfully reverses severe metabolic syndrome caused by a high-fat diet, thoroughly clears liver lipid deposits and stubborn visceral fat accumulation, and maximizes exercise endurance and efficient cellular energy circulation. Simultaneously, it achieves deep reconstruction of mitochondrial function, completely eliminates accumulated free radicals, eradicates persistent chronic low-grade inflammation, and achieves outstanding neuroprotective and anti-aging effects. The ultimate 20mg fully saturated flagship formulation perfectly matches ultra-high dose threshold screening, full-load severe metabolic damage modeling, deep advanced aging intervention, and top-tier complex peptide synergistic validation, providing authoritative and highly discriminative data for cutting-edge mitochondrial metabolic anti-aging research.

Core Product Advantages

1. Ultimate Fully Saturated Mitochondrial Pathway Activation: The industry-leading 20mg concentration fully saturates the AMPK energy-sensing pathway, maximizing mitochondrial biosynthesis and completely breaking through the metabolic efficacy limits of the MS10/MS15 version, achieving peak cellular energy conversion efficiency. 2. Exceptional Metabolic Corrective Efficacy: Possesses outstanding capabilities in reversing insulin resistance and reshaping glucose and lipids, fundamentally improving severe, refractory metabolic disorders that cannot be addressed by low- or medium-dose regimens, representing the highest metabolic regulatory efficacy of MOTS-c peptides.

3. Five-fold Synergistic Physiological Optimization: Integrates peak exercise-simulated fat burning, blood glucose stabilization, free radical anti-lipid deposition, comprehensive mitochondrial antioxidant and anti-inflammatory effects, and ultimate deep anti-aging and senescent cell clearance, achieving a complete reset of physiological homeostasis.

4. Top-Tier Pharmaceutical-Grade Ultra-Stable Process: Employs upgraded ultra-fine multi-level deep gradient purification and full-vacuum freeze-drying technology, preserving 100% of the active molecular structure, with zero impurity interference and ultra-pure experimental variables, ensuring authoritativeness.